Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease.

Castellarin M, Milne K, Zeng T, Tse K, Mayo M, Zhao Y, Webb JR, Watson PH, Nelson BH, Holt RA. Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease. J Pathol. 2013 Mar; 229(4):515-24.

View in: PubMed

subject areas

Alleles
Cystadenocarcinoma, Serous
DNA, Neoplasm
Drug Resistance, Neoplasm
Extracellular Matrix
Female
Gene Regulatory Networks
Genomics
Golgi Apparatus
Humans
Mutation
Neoplasm Recurrence, Local
Ovarian Neoplasms
Sequence Analysis, DNA
Tumor Suppressor Protein p53

authors with profiles

Robert Holt

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support